Salivary Gland Neoplasms - 16 Studies Found
| Recruiting |
: Concurrent Chemotherapy Based on Genetic Testing in Patients With High-Risk Salivary Gland Tumors :
: 2016-09-30 :
|
| Recruiting |
: Postoperative Concurrent Chemoradiotherapy in Treating Patients With High-Risk Malignant Salivary Gland Tumors :
: 2016-05-12 :
|
| Completed |
: A Randomized Phase II Study of Adjuvant Concurrent Radiation and Chemotherapy Versus Radiation Alone in Resected High-Risk Malignant Salivary Gland Tumors : Malignant Salivary Gland Tumors : 2011-12-07 :
|
| Recruiting |
: Abiraterone Acetate in Patients With Relapsed and/or Metastatic Salivary Gland Cancers : Salivary Glands Tumors : 2016-08-11 : Drug: Abiraterone acetate Abiraterone acetate is a prodrug of abiraterone, an irreversible inhibitor of |
| Recruiting |
: Radiation Therapy With or Without Chemotherapy in Treating Patients With High-Risk Malignant Salivary Gland Tumors That Have Been Removed By Surgery : Head and Neck Cancer : 2010-10-12 :
|
| Recruiting |
: A Study of Drug Therapies for Salivary Gland Cancers Based on Testing of Genes :
|
| Recruiting |
: Immunohistochemical & Immunoblot Analysis of NIS (Na+/I-Symporter) in Archival & Frozen Tissue Sample :
|
| Recruiting |
: Axitinib in R/M Salivary Gland Cancers of the Upper Aerodigestive Tract - SGC-AX14 : Salivary Gland Cancers : 2016-05-06 : Drug: Axitinib Axitinib will be self orally administered at 5 mg twice daily approximately every 12 hour |
| Recruiting |
: Study of I-125 Brachytherapy Versus Intensity-modulated Radiation Therapy to Treat Inoperable Salivary Gland Cancer : Salivary Gland Cancer : 2014-01-23 :
|
| Recruiting |
: Androgen Deprivation Therapy in Advanced Salivary Gland Cancer : Salivary Gland Cancer : 2013-09-24 :
|